|
|
News Breaks | | | | November 2, 2012 | | 10:01 EDT |  | CHE | Chemed says VITAS received subpoena from Florida AG in July Chemed disclosed in a regulatory filing that, in July 2012, VITAS received an investigative subpoena from the Florida Attorney General seeking documents previously produced in the course of prior government investigations as well as, for the period January 1, 2007 through the date of production, billing records and procedures; information concerning business results, plans, and strategies; documents concerning patient eligibility for hospice care; and certain information concerning employees and their compensation. The company stated, "We are conferring with the Attorney General regarding those document requests." | |
|
News For CHE From The Last 14 Days Check below for free stories on CHE the last two weeks. |
|
|
| May 16, 2013 | | 15:41 EDT |  | CHE | Chemed says government to intervene in previously disclosed qui tam complaints Chemed disclosed in a regulatory filing that on May 6, the U.S. District Court for the Western District of Missouri, at the request of the government, unsealed a qui tam complaint against VITAS and VITAS Healthcare Corporation of California. The complaint alleges that VITAS’ Los Angeles program falsely certified and recertified patients as eligible for the Medicare Hospice Benefit. It alleges violations of the false claims act and seeks treble damages, civil penalties, recovery of costs, attorneys’ fees and expenses, and pre- and post-judgment interest. On May 9 and 10, respectively, the government moved to intervene partially in the previously disclosed qui tam complaints filed in U.S. District Courts for the Western District of Texas and Northern District of Illinois, respectively, and transfer the cases to the U.S. District Court for the Western District of Missouri and consolidate such cases. In its motions, the government stated that it seeks to intervene partially on the allegations that VITAS submitted or caused the submission of false or fraudulent claims for continuous home care and routine home care on behalf of certain ineligible Medicare beneficiaries. | | | May 10, 2013 | | 13:01 EDT |  | CHE | Citron Research says Chemed shares headed for teens
Subscribe for More Information | | | 12:54 EDT |  | CHE | Chemed mentioned cautiously by Citron Research
Subscribe for More Information | |
|
|
|
|
|
|